On June 16, the Softbank China Capital·Medical and Health Special Event of Jinyuzui Organization Day was held in Jinyuzui Fund Block, Jianye District, Nanjing. The event focuses on "new medicine and life and health" in Nanjing's key industrial chain, and discusses the innovation and future trends of the medical and health industry.
The guests attending this event included: Yuan Ting, Deputy District Mayor of Jianye District, Secretary of the Party Working Committee of Jianye High-tech Zone, Zhao Jingbo, Vice President of Entrepreneurship, Liu Ying, Partner of Softbank China Capital, Cao Feng, Partner of Yingke Capital, Senior Manager of CDH Investment VGC Partner Liu Dan, Zhouling Capital Managing Director Chen Long, Haier Capital Industry Partner Tang Aimin, Jinyu Bogor Partner Li Hongsen, Huatai Zijin Investment Director Chen Kai, Enran Venture Capital Investment Director Deng Jintao. In addition, relevant leaders of the Jiangsu Provincial Committee of the Communist Youth League, the Biomedical Office of the Nanjing Science and Technology Bureau, the Science and Technology Department of Nanjing Medical University, and the Jiangbei Branch of Bank of Nanjing also attended the event.
This event also specially invited the relevant persons in charge of BenQ Hospital and Yuanhui Dental, as well as guests from investment institutions of various medical tracks, medical-related enterprises, and the media to participate.
100+ experts in the medical industry gather at the Golden Fish Mouth Institution Day Softbank China Capital·Medical and Health special event
In the project roadshow, 12 outstanding companies including Bogong Technology were on stage, and Liu Ying, a partner of Softbank China Capital, Cao Feng, a partner of Yingke Capital, Liu Dan, a senior partner of CDH Investment VGC, and managing director of Zhouling Capital Chen Long, Tang Aimin, industry partner of Haier Capital, and Li Hongsen, partner of Jin Yu Bogor, etc., made interactive comments and scores as judges.
Bogong Technology Roadshow Site
In the end, four companies including Bogong Technology won the highest votes in the audience, and Le Huan, a fourth-level researcher of the United Front Work Department of the Jiangsu Provincial Party Committee of the Communist Youth League, awarded them the "Most Investment Value Award" for Jinyuzui Daily Roadshow.
Jinyuzui Daily Roadshow Most Valuable Investment Award
AI+ROBOT-driven automation solution for life science scenarios
As a provider of automation solutions for life science scenarios, Bogong Technology’s advantage lies in its ability to provide "product + service" software and hardware integration of domestic stem cell cultivation automation solutions, experimental animal management solutions, medical testing intelligent solutions and many other successful applications case.
Based on the highly integrated BRC controller, create a wide range of life science robots, including incubator robots, liquid adder robots, microscope robots, collection robots, centrifuge robots, low-temperature storage robots, etc., and are constantly enriching the robot category, for Customers provide life science robots that adapt to more standard vehicles and more scenarios.
Bogong Technology has a complete solution for the large-scale preparation of cells that meets GMP standards, and has established a fully automatic production line for the preparation of cell drugs and their derivatives, subverting the traditional artificial cell production and preparation process, and realizing large-scale, automated, and standardized cell drugs The production and preparation of cell drugs and their derivative products can significantly reduce the production cost of cell drugs and their derivative products and the difference between batches of cell quality.
✦About us✦
Guangdong Bogong Medical Technology Co., Ltd. is located in the biomedical industry base of Songshan Lake National Science City. The company focuses on the design, development, production and manufacturing of automation solutions for life science scene users, and always insists on realizing automation and digital transformation for medical institution customers. New drug research and development, serving human health.
The whole company takes "let artificial intelligence achieve the beauty of medicine" as its business mission, adheres to the business philosophy of "beginning with customer needs, and finally customer satisfaction", and has a large number of domestic stem cell cultivation automation solutions, experimental animal management solutions, medical testing intelligent solutions Successful application cases.
